Skip To Main Content
Madison Muller on Muck Rack

Madison Muller

Verified
(She/Her)
New York
As seen in: Bloomberg News, MSN, MSN Ireland, MSN Philippines, UOL, Bloomberg Green Daily, MSN España, The Economic Times, The Washington Post, TIME, Yahoo Canada and
Covers:  Health, health care, Covid-19, pharmaceuticals, public health
pharma reporter @business 💊 mmuller84@bloomberg.net || signal: madisonmuller.25 || midwest raised

Get in touch with Madison

Contact Madison, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Madison Muller’s Biography

Read Full Bio →

I’m currently a health reporter for Bloomberg News in New York City. I have a bachelor’s and master’s in journalism from Northwestern University’s Medill School of Journalism. My work can be found in Bloomberg, The Washington Post, Rolling Stone and more.

Articles

イーライリリーCEO、より大型のM&A視野－製薬の「未開拓」領域狙う - Bloomberg

|
By Naomi Kresge Verified, Madison Muller Verified
| Bloomberg News Verified
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
Open in Who Shared View Duplicates (99) Issue with article?

Lilly CEO Eyes Bigger Deals in Pharma’s ‘White Spaces’ (1)

|
By Madison Muller Verified
| Bloomberg Tax Verified
Investors should expect to strike slightly larger deals, along the lines of its $7.8 billion acquisition of , as it casts a wide net for assets in the “white spaces” of science, Chief Executive Officer said. Lilly, now the world’s largest pharmaceutical company, has been on a record spending spree as it uses the windfall from its weight-loss and diabetes shots to expand into new areas that could power its next act.
Open in Who Shared Issue with article?

Lilly CEO Eyes Bigger Deals in Hunt for Pharma’s ‘White Spaces’

|
By Madison Muller Verified
| Bloomberg Tax Verified
Investors should expect to strike slightly larger deals, along the lines of its $7.8 billion acquisition of , as it casts a wide net for assets in the “white spaces” of science, Chief Executive Officer said. Lilly, now the world’s largest pharmaceutical company, has been on a record spending spree as it uses the windfall from its weight-loss and diabetes shots to expand into new areas that could power its next act.
Open in Who Shared Issue with article?
See all 4,680 licensed articles (4,890 Total)

Interview

See all →

Have you ever used a typewriter?

Nope

How is social media changing news?

It’s putting the power to share information and stories into everyone’s hands

What's your favorite social network?

Instagram